Single chromosomal abnormalities in Philadelphia-negative chronic myeloproliferative disorders

In Vivo

Volumn 21, Issue 5, 2007, Pages 867-870

  Panani, Anna D ^a  

^a UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

Author keywords

Conventional cytogenetics; Myeloproliferative disorders; Philadelphia negative; Single chromosome abnormalities

Indexed keywords

ARTICLE; CHROMOSOME ABERRATION; CHRONIC DISEASE; CONTROLLED STUDY; CYTOGENETICS; DISEASE CLASSIFICATION; FREQUENCY ANALYSIS; GENETIC IDENTIFICATION; HUMAN; MAJOR CLINICAL STUDY; MONOSOMY; MONOSOMY 10; MONOSOMY 14; MONOSOMY 7; MYELOPROLIFERATIVE DISORDER;

EID: 35648962370     PISSN: 0258851X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Bench AJ, Cross NCP, Huntly BJP, Nacheva EP and Green AR: Myeloproliferative disorders. Best Pract Res Clin Haematol 14: 531-551, 2001.
2. Tefferi A: Classic and atypical myeloproliferative disorders. Best Pract Res Clin Haematol 19: 361-364, 2006.
3. Panani AD: Cytogenetic and molecular aspects of Philadelphia negative chronic myeloproliferative disorders: Clinical implications. Cancer Lett 255: 12-25, 2007.
4. Chen Z and Sandberg Ak Molecular cytogenetics aspects of hematological malignancies: clinical implications. Am J Med Genet (Semin Med Genet) 115: 130-141, 2002.
5. Diez Martin JL, Graham DL, Petitt RM and DeWald GW: Chromosome studies in 104 patients with polycythemia vera. Mayo Clin Proc 68: 287-299, 1991.
6. Bench AJ and Pahl HL: Chromosomal abnormalities and molecular markers in myeloproliferative disorders. Semin Hematol 42: 196-205, 2005.
7. Bench AJ, Nacheva EP, Champion KM and Green AR: Molecular genetics and cytogenetics of myeloproliferative disorders. Baillieres Best Pract Res Clin Haematol 11: 819-848, 1998.
8. Reilly JT, Snowden JA, Spearing RL, Fitzgerald PM, Jones N, Watmore A and Potter A: Cytogenetic abnormalities and their prognostic significance in idiopathic myelofibrosis: a study of 106 cases. Brit J Haematol 98: 96-102, 1997.
9. Bacher U, Haferlach T, Kern W, Hiddemann W, Schnittger S and Schoch C: Conventional cytogenetics of myeloproliferative diseases other than CML contribute valid information. Ann Hematol 84: 250-257, 2005.
10. Andrieux J, Demory JL, Caulier MT, Agape P, Watterwald M, Bauters F and Lai JL: Karyotypic abnormalities in myelofibrosis following polycythemia vera. Cancer Genet Cytogenet 140: 118-123, 2003.
11. Dingli D, Schwager SM, Mesa RA, Li C-Y, Dewald GW and Tefferi A: Presence of unfavorable cytogenetic abnormalities is the strongest predictor of poor survival in secondary myelofibrosis. Cancer 106: 1985-1989, 2006.
12. Tefferi A, Mesa RA, Schroeder G, Hanson CA, Li C-Y and Dewald GW: Cytogenetic findings and their clinical relevance in myelofibrosis with myeloid metaplasia. Br J Haematol 113: 763-771, 2001.
13. Mitelman F (ed.): (ISCN 1995) An International System for Human Cytogenetic Nomenclature. Basel: S. Karger, 1995.
14. Panani AD: Cytogenetic findings in untreated patients with essential thrombocythemia. In Vivo 20: 381-384, 2006.
15. Al-Assar O, Ul-Hassan A, Brown R, Wilson GA, Hammond DW and Reilly JT: Gains on 9p are common genomic aberrations in idiopathic myelofibrosis: a comparative genomic hybridization study. Br J Haematol 129: 66-71, 2005.
16. Gardiner A, Corcoran M, Ibbotson R, Potter A, Reilly J and Oscier D: An analysis of chromosome 13q14 deletions in myelofibrosis using FISH and Southern-based hybridization. Blood 90(suppl I): 4062-4062, 1997.
17. Pastore C, Nomdedeu J, Volpe G, Guerrasio A, Cambrin GR, Parvis G, Pautasso M, Daglio C, Mazza U, Saglio G and Gaidano G: Genetic analysis of chromosome 13 deletions in BCR/ABL negative chronic myeloproliferative disorders. Genes Chromosomes Cancer 14: 106-111, 1995.
18. Gozzetti A, Crupi R, Tozzuoli D, Fabbri A, Bocchia M and Lauria F: Trisomy 13 in a patient with idiopathic myelofibrosis. Cancer Genet Cytogenet 156: 185-185, 2005.
19. Mitelman F, Johansson B and Mertens F (eds.): Mitelman Database of Chromosome Aberration in Cancer (2007). http://cgap.nci.nih.gov/ Chromosomes/Mitelman.
20. Ferrara F, Vicari L, Festa B, Di Noto R, Pane F, Sebastio L and Cimino R: Trisomy 13 in a case of myelofibrosis with myeloid metaplasia with early blastic transformation. Haematologica 80: 434-436, 1995.
21. Panani AD, Pappa V, Papageorgiou S, Stamatelli F and Raptis S: Deletion of (11)(q13) as the sole anomaly in myeloid malignancies: four new cases and a short review. Ann Hematol 83: 153-155, 2004.
22. Sessarego M, Ajmar F, Ravazzolo R, Bianchi Scarra GL, Carre C and Boccaccio P: Coincidence between fragile site expression and interstitial deletion of chromosome 11 in a case of myelofibrosis. Hum Genet 63: 299-301, 1983.
23. Mesa RA, Li C-Y, Ketterling RP, Schroeder GS, Knudson RA and Tefferi A: Leukemic transformation in myelofibrosis with myeloid metaplasia: a single institution experience with 91 cases. Blood 105: 973-977, 2005.
24. Strasser-Weippl K, Steurer M, Kees M, Augustin F, Tzankov A, Dimhofer S, Fiegl M, Gissinger H, Zojer N and Ludwig H: Chromosome 7 deletions are associated with unfavorable prognosis in myelofibrosis with myeloid metaplasia. Blood 105: 4146-4146, 2005.
25. Khwaja A: The role of Janus kinases in haemopoiesis and haematological malignancy. Br J Haematol 134: 366-384, 2006.
26. Tefferi A, Strand JJ, Lasho TL, Elliot M, Li C-Y, Mesa R and Dewald GW: Respective clustering of unfavorable and favorable cytogenetic clones in myelofibrosis with myeloid metaplasia with homozygosity for JAK2V617F and response to erythropoietin therapy. Cancer 106: 1739-1743, 2006.